Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
AIkido Pharma Inc. - Common Stock
(NQ:
AIKI
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Dec 21, 2022
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about AIkido Pharma Inc. - Common Stock
< Previous
1
2
Next >
AIkido Pharma Has Pending Data Results on June 4th, with Strongest Balance Sheet in Its History While Trading Below Cash
May 20, 2021
New York, New York--(Newsfile Corp. - May 20, 2021) - PCG Digital -- Anthony Hayes is an optimist, with good...
Via
Newsfile
Topics
Intellectual Property
AIKI Featured as Stock to Watch Ahead of Significant Key Milestones
May 19, 2021
New York, New York--(Newsfile Corp. - May 19, 2021) - PCG Digital -- Continuing the barrage of good-news announcements that...
Via
Newsfile
AIKI's Near Term Catalyst Approaching this Quarter with Strong Cash Balance Sheet for Strategic Initiatives
May 13, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Intellectual Property
AIKI's Near Term Catalyst Approaching this Quarter with Strong Cash Balance Sheet for Strategic Initiatives
May 13, 2021
New York, New York--(Newsfile Corp. - May 13, 2021) - PCG Digital -- Things seem to be heating up for...
Via
Newsfile
Topics
Intellectual Property
2 Robinhood Medical Favorites Are Looking Healthy
April 28, 2021
The SPDR S&P 500 (NYSE: SPY) hit a new all-time high Wednesday morning amid a week where many of the biggest tech companies report earnings. A boom in big board names is...
Via
Benzinga
Topics
Stocks
Aikido Secures Sublicense For Psilocybin Treatment of Neuro-Inflamed Tissue in Cancer Patients
April 07, 2021
Aikido Pharma Inc (NASDAQ: AIKI) has been granted an exclusive sublicense to technology related to the use of the central nervous system (CNS) homing peptides...
Via
Benzinga
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.